In view of the COVID‐19 pandemic and the reports of co‐occurrence of NMS and COVID‐1919 and elevated ESR and CRP, this patient also underwent a PCR test for COVID‐19 which was negative. This evidence concerns the gene ESR1 and neuroleptic malignant syndrome.